Together with our aforementioned findings that PLK1 and STAT3 are crucial regulators of EGFR-TKI sensitivity in NSCLC cells, we subsequently investigated their regulatory relationship with FGFR1 in EGFR-TKI-resistant cell lines. This evidence concerns the gene PLK1 and non-small cell lung carcinoma.